BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9952188)

  • 1. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1999 Feb; 281(5):408. PubMed ID: 9952188
    [No Abstract]   [Full Text] [Related]  

  • 2. Availability of Lyme disease vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):35-6, 43. PubMed ID: 9933128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme disease vaccine safe for all?
    Rahn DW
    Postgrad Med; 1999 Jun; 105(7):21. PubMed ID: 10376044
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lyme borreliosis--vaccines in the "pipeline"].
    Kramer M
    MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization against Lyme disease--an important first step.
    Steigbigel RT; Benach JL
    N Engl J Med; 1998 Jul; 339(4):263-4. PubMed ID: 9673306
    [No Abstract]   [Full Text] [Related]  

  • 6. Lyme disease vaccine cleared for marketing.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):206. PubMed ID: 10030501
    [No Abstract]   [Full Text] [Related]  

  • 7. Borrelia burgdorferi outer surface protein A vaccine: importance, role, and value.
    Sigal LH
    J Pediatr; 1999 Nov; 135(5):539-41. PubMed ID: 10547238
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-OspA antibody reduces reservoir competence of mice for Borrelia burgdorferi, the agent of Lyme disease.
    Brunet LR; Katavolos P; Spielman A; Telford SR
    Med Vet Entomol; 1997 Apr; 11(2):198-200. PubMed ID: 9226653
    [No Abstract]   [Full Text] [Related]  

  • 9. The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccine.
    Wallich R; Kramer MD; Simon MM
    Infection; 1996; 24(5):396-7. PubMed ID: 8923055
    [No Abstract]   [Full Text] [Related]  

  • 10. The Lyme disease vaccine: conception, development, and implementation.
    Thanassi WT; Schoen RT
    Ann Intern Med; 2000 Apr; 132(8):661-8. PubMed ID: 10766685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Lyme disease after OspA vaccine.
    Schutzer SE; Luan J; Coyle PK
    N Engl J Med; 1997 Sep; 337(11):794-5. PubMed ID: 9289653
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic vaccination against Lyme borreliosis for man and dogs and new strategies to treat established B. burgdorferi infections.
    Wallich R; Jahraus O; Simon MM
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():147-9. PubMed ID: 12141739
    [No Abstract]   [Full Text] [Related]  

  • 13. A recombinant vaccine for Lyme disease.
    Wallich R; Kramer MD; Simon MM
    Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on OspA: a source of new paradigms in Lyme disease research.
    Philipp MT
    Trends Microbiol; 1998 Feb; 6(2):44-7. PubMed ID: 9507636
    [No Abstract]   [Full Text] [Related]  

  • 15. An effective vaccine against Lyme disease.
    Crooy P; Lobet Y
    J Biotechnol; 2000 Jan; 76(2-3):261-3. PubMed ID: 10656342
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
    Steere AC; Sikand VK; Meurice F; Parenti DL; Fikrig E; Schoen RT; Nowakowski J; Schmid CH; Laukamp S; Buscarino C; Krause DS
    N Engl J Med; 1998 Jul; 339(4):209-15. PubMed ID: 9673298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping Lyme disease at bay. An integrated approach to prevention.
    Wade CF
    Am J Nurs; 2000 Jul; 100(7):26-31; quiz 32. PubMed ID: 10914066
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyme disease vaccine.
    Schofield DH; Parenti D
    JAMA; 2000 Jan; 283(2):199; author reply 200. PubMed ID: 10634331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.